Differences in clinical and functional outcomes of atrial fibrillation in women and men: Reply

TY - JOUR

T1 - Differences in clinical and functional outcomes of atrial fibrillation in women and men

T2 - Reply

AU - Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Investigators and Patients

AU - Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Investigators and Patients

AU - Piccini, Jonathan P.

AU - Peterson, Eric D.

N1 - Funding Information: Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Piccini receives significant research support from ARCA Biopharma, Boston Scientific, GE Healthcare, and Janssen Scientific Affairs and provides consultation for Forest Laboratories, Janssen Scientific Affairs, Pfizer/Bristol-Myers Squibb, Spectranetics, and Medtronic. No other disclosures were reported. Group Information: The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Investigators and Patients includes the following: Richard Borge, MD (Abington Medical Specialists, Abington, Pennsylvania); Stephen Voyce, MD (Advanced Cardiology Specialists, Scranton, Pennsylvania); Ajay Labroo, MD (Advanced Cardiovascular Consultants, Rock Island, Illinois); Salwan Anton, DO (Advanced Cardiovascular Health Specialists, Livonia, Michigan); Barry Collins, MD (Advanced Clinical Research, Pell City, Alabama); Anthony Alfieri, MD (Alfieri Cardiology, Newark, Delaware); Zachary Seymour, MD (AnMed Hospital, Anderson, South Carolina); Roger Guthrie, MD (Arroyo Medical Group, Pismo Beach, California); Elvin Rivera-Zayas, MD (Ashford Medical Center, San Juan, Puerto Rico); Steven Rosenthal (Atlanta Institute for Medical Research, Decatur, Georgia); Anthony Frey, MD (Atlantic Cardiology Associates, Salisbury, Maryland); Debra Weinstein, MD (Atlantic Clinical Research, Boynton Beach, Florida); William Long, MD (Barat Research, Charlotte, North Carolina); Daniel Lee, MD (Bay Regional Medical Center, Bay City, Michigan); Brian Snoddy (Birmingham Heart Clinic, Birmingham, Alabama); David Williams, MD (Black Warrior Research, Tuscaloosa, Alabama); Kenneth LeClerc (Brooke Army Medical Center, Fort Sam Houston, Texas); Tom Christensen, MD (Calabash Medical Center, Calabash, North Carolina); Naseem Jaffrani, MD (Cambridge Medical Trials, Alexandria, Louisiana); Daniel Fisher, MD (Capitol Interventional Cardiology, Carmichael, California); Jay Kozlowski, MD (Cardiology and Vascular Associates, Huron Valley Sinai Hospital, Commerce, Michigan); John Pappas, MD (Cardiology Associates of Corpus Christi, Corpus Christi, Texas); Ravi Bhagwat, MD (Cardiology Associates of Northwest Indiana, Hammond); Mark Lebenthal, MD (Cardiology Associates of Somerset County, Bridgewater, New Jersey); Glenn Jacobs (Cardiology Consultants, Toms River, New Jersey); Paul Grena, DO (Cardiology Consultants of Philadelphia, Yardley, Pennsylvania); Shaival Kapadia (Cardiovascular Association of Virginia, Midlothian); Mark Gelernt, MD (Cardiovascular Associates of the Delaware Valley, Elmer, New Jersey); Harvey Snyder (Cardiovascular Associates of the Delaware Valley, Haddon Heights, New Jersey); Jeffrey Kramer, MD (Cardiovascular Associates of the Delaware Valley, Sewell, New Jersey); John Berry, MD (Cardiovascular Associates, Kingsport, Tennessee); Soufian AlMahameed (Carilion Clinic, Roanoke, Virginia); Benjamin Rhee, MD (Carle Foundation Hospital, Urbana, Illinois); Matthew Sackett, MD (Centra Medical Group, Lynchburg, Virginia); Joseph McGarvey, MD (Central Bucks Specialists, Doylestown, Pennsylvania); Charles R. Leach (Private Practice, Arlington, Texas); David Hotchkiss, MD (Charlotte Cardiovascular Institute, Port Charlotte, Florida); Jeffrey S. Fierstein (Clinlogix Spring House Corporate Center, Spring House, Pennsylvania); William Reiter (Community Hospital of Anaconda, Anaconda, Montana); Jeffrey Shanes, MD (Consultants in Cardiovascular Medicine, Melrose Park, Illinois); Amy Arouni (Creighton Cardiac Center, Omaha, Nebraska); Rahul Aggarwal, MD (CVMS Research Institute, Jupiter, Florida); Frank Waxman, MD (Deerfield Beach Cardiology Associates, Deerfield Beach, Florida); Rene Casanova, MD (Deerfield Beach Cardiology Research, Oakland Park, Florida); Denis Ruiz-Serrano, MD (Denis Ruiz Serrano Cardologia, Rio Grande, Puerto Rico); Robert Detweiler, DO (Detweiler Family Medicine and Associates, Lansdale, Pennsylvania); Paz Eilat, MD (Devise Research, Torrance, California); Ramin Farsad, MD (Diagnamics, Carlsbad, California); Augusto Focil, MD (Diverse Research Solutions, Oxnard, California); Michael B. Schwartz, MD (DuPage Medical Group, Winfield, Illinois); Brett Atwater, MD (Durham VAMC, Durham, North Carolina); Donald Fox, MD (Eastwick Primary Care, Philadelphia, Pennsylvania); James Capo, MD (Executive Health and Research Associates, Atlanta, Georgia); Andrew Drabick, MD (Family Medical Associates of Raleigh, Raleigh, North Carolina); Youssef Al-Saghir, MD (First Coast Cardiovascular Institute, Orange Park, Florida); Calvin Snipes, MD (Foothills Internal Medicine, Easley, South Carolina); Santosh Gill, MD, MBA (Fox Valley Clinical Research Center, Aurora, Illinois); Tahir Tak, MD (Franciscan Healthcare/Mayo Health System, La Crosse, Wisconsin); Eric Batres, MD (Futura Research, Montebello, California); Peter Berger, MD (Geisinger Medical Center, Danville, Pennsylvania); Matthew Ebinger (Genesys Regional Medical Center, Grand Blanc, Michigan); Cezar Staniloae, MD (Gotham Cardiovascular Research, New York, New York); Gary Sutter (HealthCare

PY - 2017/1

Y1 - 2017/1

UR - http://www.scopus.com/inward/record.url?scp=85031318703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031318703&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2016.3711

DO - 10.1001/jamacardio.2016.3711

M3 - Letter

C2 - 27784042

AN - SCOPUS:85031318703

SN - 2380-6583

VL - 2

SP - 108

EP - 110

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 1

ER -